Report Scope: The global enteral feeding devices market generally consists of enteral feeding pumps, oroenteric tubes, cardiac monitors, nasoenteric tubes (sub-segmented into nasojejunal, nasoduodenal and nasogastric tube), gastrostomy tubes (sub-segmented into percutaneous endoscopic gastrostomy devices and low-profile gastrostomy device) and jejunostomy tubes (sub-segmented into percutaneous endoscopic jejunostomy and percutaneous radiological jejunostomy tubes). This report does not include other medical devices used in hospitals.
The scope of the report includes an overview of the global market for enteral feeding devices and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.
The report discusses technological, application, regulatory and economic trends that impact the market. It also explains the major drivers and regional dynamics of the global market and current trends within the industry.
Enteral feeding devices end users are categorized into hospitals, homecare settings and ambulatory surgical centers. Regional analysis includes North America (U.S., Canada), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan and Rest of Asia-Pacific), South America, and the Middle East and Africa.
The report concludes with detailed profiles of the major vendors in the global enteral feeding devices market.
Report Includes: - 24 data tables and 19 additional tables - An overview of the global enteral feeding devices market - Analyses of the global market trends, with corresponding market analysis data for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025 - Highlights of current and future market potential for various equipment used in enteral feeding devices, as well as its product segments and key market developments - Estimation of the market size and market forecast for enteral feeding devices, with detailed market share analysis on the basis of product types and their subsegments, end users, application areas, and major geographical regions - Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, and other emerging economies - Insights into the current market trends, opportunities and restraints, regulatory framework, and industry value chain analysis of the enteral feeding market - Impact of COVID-19 pandemic on enteral feeding medical devices and product sub-segments - Regulatory structures and parameters required for approval or clearance of enteral feeding medical devices in some key countries - Profile descriptions of the leading market participants, including Abbott, Fresenius Kabi AG, Boston Scientific Corp., Medtronic (Covidien), Nestlé S.A. and Groupe Danone
Summary: The global enteral feeding devices market was worth nearly $REDACTED billion in 2019.The market is expected to increase at a compound annual growth rate (CAGR) of REDACTED% during the forecast period of 2020 to 2025.
Increased pre- term birth rates, aging population growth, increased prevalence of chronic diseases such as diabetes, cancer, GI and neurological disorders, and increased awareness of enteral nutrition, aswell as rapid healthcare progress in emerging countries, are expected to drive the market, as is the increase need for enteral feeding devices such as feeding tubes and administration sets for COVID-19 care. However, the market is restrained due to factors such as high competitiveness and pricing pressure.
Our reports have been used by over 10K customers, including:
The implementation of track and trace solutions and technologies is an important strategy adopted by many manufacturing companies and regulatory bodies in recent years. The global track and trace solutions market is projected to reach USD 7.3 billion by 2026 from USD 4.1 billion in 2021, at a CAGR of 12.1% during the forecast period. Growth...
The global single-use assemblies market is projected to reach USD 6.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 23.3% during the forecast period. The growth of the single-use assemblies market can primarily be attributed to the major advantages of single-use technologies as compared to traditional stainless-steel assemblies,...
531 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• May 2021
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development, manufacturing, and formulation due to rise in population, increase in chronic diseases like infectious diseases, oncology, cardiovascular disorders, rising healthcare expenditures, collaborations,...
The pharmaceutical intermediate market was valued at US$ 27,356.70 million in 2020 and is projected to reach US$ 37,290.33 million by 2028; it is expected to grow at a CAGR of 4.2% from 2021 to 2028. The rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities...
Bromodomain Containing Protein 2 - Drugs In Development, 2021 Summary According to the recently published report ’Bromodomain Containing Protein 2 - Drugs In Development, 2021’; Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) pipeline Target constitutes...
5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B is a protein encoded by the HTR2B gene. It plays a role in the regulation of behavior,...
175 pages •
By The Business Research Company
• Jun 2021
Major players in the hypolipidemic drugs market are ABBOTT LABORATORIES LIMITED, Apotex Fermentation Inc., Biocon Limited, Cadila Healthcare Limited and Chunghwa Chem Syn& Biotech Co., Ltd. The global hypolipidemics market is expected to decline from $16.23 billion in 2020 to $15.94 billion in 2021 at a compound annual growth rate (CAGR)...
The global single-use bioprocessing market exhibited strong growth during 2015-2020. Single-use bioprocessing, or disposables, consists of various pharmaceutical solutions and products that are designed to be used once and then discarded. Media bags, containers, filtration assemblies, single-use bioreactors, disposable...
175 pages •
By The Business Research Company
• Jun 2021
Major players in the enzymes market are Sanofi, AbbVie Inc., Alexion Pharmaceuticals Inc, Horizon Pharma, Allergan plc, Pfizer Inc., Vivus, Digestive Care, Leadiant Biosciences, and Roche Holdings AG The global enzymes market is expected to grow from $7.81 billion in 2020 to $8.9 billion in 2021 at a compound annual growth rate (CAGR)...
Digestive System Disorder
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.